Steadfast Limited - Due diligence report

A 360° intelligence report on Steadfast Medishield: trust score, financial health, credit view, compliance, directors, growth and distress s…

2008-10-20 New Delhi, Delhi Active Unlisted Active Compliant
Share
Connect MCP
SL Steadfast Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Steadfast Medishield — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Steadfast Medishield is assessed as Low Risk with a Trust Score of 78/100. Steadfast Medishield is an active public limited indian non-government company incorporated in 2008, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 28 Jul 2026 from the latest processed filings. Steadfast Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
74/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
90/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Open charges exceed net worth - secured lenders rank ahead.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 6 open (62.85 cr) · 1 satisfied (1.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited3 48.0 cr
Others2 48.0 cr
Kotak Mahindra Bank Limited1 48.0 cr
Axis Bank Limited1 48.0 cr
Compliance Score: 74/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 2 court forum(s).
  • 6 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 45/100
NameDIN / PANDesignationAppointedTenureDIN status
YOGESH PURI 01234567 Director 01/04/2018 6 yrs Approved
LEENA PURI 01234567 Director 01/04/2018 6 yrs Approved
KETAN RAJENDRA GADKARI 01234567 Director 01/04/2018 6 yrs Approved
AMAN PURI 01234567 Director 01/04/2018 6 yrs Approved
SUBRATO KUNDU 01234567 Director 01/04/2018 6 yrs Approved
Puneet Minocha 01234567 Director 01/04/2018 6 yrs Approved
Charles David Vijayarajan 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • KETAN RAJENDRA GADKARI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: YOGESH PURI (Managing Director) · AMAN PURI (CEO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 90 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 17+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 24% in a year.
6 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 6 open charge(s) of 62.85 cr already registered.
  • Compliance record supports lending.
Investor view87/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
19 Sep 2025
Director appointed
KETAN RAJENDRA GADKARI (Director)
Director appointed
SUBRATO KUNDU (Director)
Director appointed
Puneet Minocha (Director)
Director appointed
Charles David Vijayarajan (Director)
01 Apr 2025
Director appointed
AMAN PURI (CEO)
31 Mar 2025
Director ceased
YOGESH PURI
30 Sep 2024
Charge created
Others - 1.27 cr
05 Aug 2024
Charge created
Axis Bank Limited - 14.13 Lakh
31 Mar 2024
Latest balance sheet
Filed with ROC
02 Mar 2024
Charge created
Hdfc Bank Limited - 27.00 Lakh
30 Sep 2023
Last AGM held
Annual general meeting
20 Oct 2021
Charge created
Hdfc Bank Limited - 58.00 cr
18 Jun 2021
Charge satisfied
Kotak Mahindra Bank Limited
20 May 2021
Charge created
Others - 2.90 cr
29 Sep 2017
Director ceased
AMAN PURI
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
7 active director(s) / partner(s); review board churn before relying on management continuity.
6 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Buzil Rossari U24297MH2013PTC251413 Mumbai, Maharashtra, India
Og Corporation India Private Limited U24233MH2013FTC247035 Mumbai, Maharashtra, India
Tricon Enterprises Private Limited U51900MH1993PTC071971 Mumbai, Maharashtra, India
Bhudeva Polymers Private Limited U25200KA2012PTC064567 Bangalore, Karnataka, India
Kami Colourcera Private Limited U24300GJ2018PTC101284 Morbi, Gujarat, India
Manoj Brothers Private Limited U26943DL2011PTC217240 Delhi, Delhi, India
Auro Sundram International Private Limited U70200BR2006PTC052235 Patna, Bihar, India
Swaranbhumi Tradelink Private Limited U51909WB2011PTC156714 Siliguri, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Steadfast Medishield before audits and certifications: compliance score 74/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Steadfast Medishield: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 90/100, margin trends, ownership structure and peer set for Steadfast Medishield - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Steadfast Medishield pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Steadfast Medishield - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Steadfast Medishield an active company?

Steadfast Medishield has MCA status “Active” with a compliance score of 74/100 (Moderate).

Is Steadfast Medishield financially healthy?

Steadfast Medishield has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Steadfast Medishield?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Steadfast Medishield?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 7 active director(s) are on record.

Does Steadfast Medishield have loans or charges against its assets?

6 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Steadfast Medishield up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 74/100 (Moderate).

Is it risky to lend to Steadfast Medishield?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.